Aerovate Therapeutics (AVTE) Q3 2024 Earnings

Aug 12Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.86
-0.8
-0.74
-0.68

Details

Expected EPS
-0.82236
Actual EPS
-0.86
Surprise EPS
-0.04
Surprise Percent
-4.58%

Description

⁨Aerovate Therapeutics⁩ (⁦AVTE⁩) has reported earnings of ⁦-0.86⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts